John Park , M.D.
| University of California, San Francisco | |
| email: jpark@cc.ucsf.edu | |
Grants
| BCT.org: Feasibility of a Clinical Trial Matching Tool | 2003 (Cycle IX) | ||
| TRC (Translational Research Collaboration) Pilot Awards | 9DB-0070 | $99,200 | |
| Targeted gene therapy using anti-pl85HER2 immunoliposomes | 1996 (Cycle II) | ||
| ITaMoCAs | 2CB-0250 | $205,410 | |
| Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery | ||||
| Periodical: Clinical Cancer Research | ||||
| Author(s): Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, et al. | ||||
| Yr: 2002 | Vol: 8 | Nbr: 4 | Pgs: 1172-81 | |
| Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes | ||||
| Tumor targeting using anti-her2 immunoliposomes | ||||
| Periodical: Journal of Controlled Release | ||||
| Author(s): Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks J, et al. | ||||
| Yr: 2001 | Vol: 74 | Nbr: 1-3 | Pgs: 95-113 | |
| Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes | ||||
| Targeting Ets-linked promoter structure to repress erbB2 transcription | ||||
| Periodical: Proceedings of the American Association for Cancer Research | ||||
| Author(s): Scott G, Chang C, Xiong X, Ren S, Park JW, and Benz C | ||||
| Yr: 1998 | Vol: 39 | Nbr: | Pgs: 180 | |
| Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes | ||||
| Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides | ||||
| Periodical: Journal of Biological Chemistry | ||||
| Author(s): Meyer O, Kirpotin D, Hong K, Sternberg B, Park JW,Woodle MC, and Papahadjopoulos D | ||||
| Yr: 1998 | Vol: 273 | Nbr: 25 | Pgs: 15621-15627 | |
| Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes | ||||
| Immunotargeting of sterically stabilized liposomes to solid tumors: the case of anti-HER2 immunoliposomes | ||||
| Periodical: Journal of Liposome Research | ||||
| Author(s): Kirpotin DB, Park JW, Hong K, Shao Y, Shalaby R, Colbern G, Benz C,and Papahadjopoulos D | ||||
| Yr: 1998 | Vol: 7 | Nbr: | Pgs: 391-417 | |
| Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes | ||||
| Immunoliposomes for cancer treatment | ||||
| Periodical: Advances in Pharmacology | ||||
| Author(s): Park JW, Hong KL, Kirpotin D, Papahadjoupolos D, Benz CC | ||||
| Yr: 1997 | Vol: 40 | Nbr: | Pgs: 399-435 | |
| Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes | ||||
| Development of liposome-and anti-HER2 immunoliposome-plasmid complexes for gene delivery | ||||
| Periodical: Proceedings of the American Association for Cancer Research | ||||
| Author(s): Park JW, Hong K, Zheng W, Benz CC, Papahadjopoulos D | ||||
| Yr: 1997 | Vol: 38 | Nbr: | Pgs: 342 | |
| Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes | ||||
| Sterically stabilized immunoliposomes: formulations for delivery of drugs and genes of tumor cells in vivo | ||||
| Periodical: NATO ASI: Targeting of Drugs: Advances in System Constructs | ||||
| Author(s): Papahadjopoulos D, Kirpotin D, Hong K, Zheng W, Shao Y, Park JW, and Benz CC | ||||
| Yr: 1997 | Vol: | Nbr: | Pgs: | |
| Associated Grant: Targeted gene therapy using anti-pl85HER2 immunoliposomes | ||||
